Ibogaine Resource Library

What Ibogaine Is — and What This Library Is

Ibogaine is an isolated psychoactive alkaloid extracted from the root bark of Tabernanthe iboga, a West African shrub used ceremonially for centuries by the Bwiti of Gabon. In modern clinical use, ibogaine is not a ceremony. It is a pharmacologically active compound administered under continuous cardiac monitoring inside a licensed medical facility, and it is one of the most powerful known interrupters of opioid dependency. Patients on heroin, fentanyl, oxycodone, and long-acting agonists routinely emerge from a single medically supervised ibogaine session without withdrawal symptoms — a result no other pharmacological agent produces.

That capacity — the receptor reset, the elimination of acute withdrawal, the interruption of craving — is why serious research programs and licensed clinics have been building around ibogaine for two decades. It is also why the drug is dangerous in the wrong setting. Ibogaine prolongs the QT interval of the cardiac cycle, which in a patient with undiagnosed structural heart disease or electrolyte imbalance can produce a fatal arrhythmia. Every ibogaine death on record traces back to inadequate screening, poor monitoring, or administration outside a properly equipped medical environment. Screening is not a formality. It is the difference between a treatment and an obituary.

How to Use This Library

If ibogaine is new to you, start with the Ibogaine Treatment page, then read What Is Ibogaine and the mechanism-of-action piece. If you are researching safety before choosing any provider, the Safety & Cardiac Screening section is required reading — the cardiac screening article in particular. If you are researching for addiction — heroin, fentanyl, or long-acting opioid dependency — the Ibogaine for Addiction section is where the clinical case is made in depth. If you are evaluating cost or geography, the Cost & Logistics section covers the U.S., Mexican, Canadian, and UAE landscapes honestly.

Who This Library Is For

This library is written for adults, families, and clinicians evaluating ibogaine as a serious medical option — usually for opioid dependency that has not resolved through conventional treatment. It is not written for the curious or the recreational. Every article on this site is medically reviewed. Every safety claim is grounded in the clinical record. Sanctuary Tulum operates a licensed medical facility in Mexico and has maintained a documented zero-fatality record across more than a decade of medically supervised ibogaine treatment. That record exists because we do not compromise on screening. If you or a family member is considering ibogaine anywhere, use this library to build the questions you need to ask any provider before you give them your trust.

Ibogaine is not FDA-approved in the United States and is not administered on U.S. soil under conventional medical practice. Sanctuary Tulum's ibogaine treatment is delivered in Mexico under federal health licensing with continuous physician supervision.